Company
Headquarters: Plan-les-Ouates, Switzerland
Employees: 4
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
SES Solar Inc. develops and delivers products in the field of photovoltaic energy in Switzerland. The company offers a range of photovoltaic products, such as solar tiles that comprise standard panels primarily for urban or rural areas, and flat or sloped roofs; and custom/architecturally integrated panels made of glass/glass tedlar, which are used for glazing, light admitting apertures in industrial and residential buildings, as well as for veranda roofs. It also handles project management services from design to completion, as well as provides monitoring (supervision), maintenance, and operation services. The company was founded in 2001 and is based in Plan-les-Ouates, Switzerland. As of November 23, 2010, SES Solar Inc. operates as a subsidiary of Flannel Management Sà rl.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
SES Solar, Inc. has the following listings and related stock indices.
Stock: OTC: SESI wb_incandescent